Cargando…

Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation

Tauopathy, a major pathology in Alzheimer's disease, is also found in ∼50% of frontotemporal dementias (FTDs). Tau transcript, a product of a single gene, undergoes alternative splicing to yield 6 protein species, each with either 3 or 4 microtubule binding repeat domains (tau 3R or 4R, associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirer, Yulie, Malishkevich, Anna, Ophir, Yotam, Lewis, Jada, Giladi, Eliezer, Gozes, Illana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906161/
https://www.ncbi.nlm.nih.gov/pubmed/24489906
http://dx.doi.org/10.1371/journal.pone.0087383
_version_ 1782301451337334784
author Schirer, Yulie
Malishkevich, Anna
Ophir, Yotam
Lewis, Jada
Giladi, Eliezer
Gozes, Illana
author_facet Schirer, Yulie
Malishkevich, Anna
Ophir, Yotam
Lewis, Jada
Giladi, Eliezer
Gozes, Illana
author_sort Schirer, Yulie
collection PubMed
description Tauopathy, a major pathology in Alzheimer's disease, is also found in ∼50% of frontotemporal dementias (FTDs). Tau transcript, a product of a single gene, undergoes alternative splicing to yield 6 protein species, each with either 3 or 4 microtubule binding repeat domains (tau 3R or 4R, associated with dynamic and stable microtubules, respectively). While the healthy human brain shows a 1/1 ratio of tau 3R/4R, this ratio may be dramatically changed in the FTD brain. We have previously discovered that activity-dependent neuroprotective protein (ADNP) is essential for brain formation in the mouse, with ADNP+/− mice exhibiting tauopathy, age-driven neurodegeneration and behavioral deficits. Here, in transgenic mice overexpressing a mutated tau 4R species, in the cerebral cortex but not in the cerebellum, we showed significantly increased ADNP expression (∼3-fold transcripts) in the cerebral cortex of young transgenic mice (∼disease onset), but not in the cerebellum, as compared to control littermates. The transgene-age-related increased ADNP expression paralleled augmented dynamic tau 3R transcript level compared to control littermates. Blocking mutated tau 4R transgene expression resulted in normalization of ADNP and tau 3R expression. ADNP was previously shown to be a member of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex. Here, Brahma (Brm), a component of the SWI/SNF complex regulating alternative splicing, showed a similar developmental expression pattern to ADNP. Immunoprecipitations further suggested Brm-ADNP interaction coupled to ADNP - polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF)-binding, with PSF being a direct regulator of tau transcript splicing. It should be noted that although we have shown a correlation between levels of ADNP and tau isoform expression three months of age, we are not presenting evidence of a direct link between the two. Future research into ADNP/tau relations is warranted.
format Online
Article
Text
id pubmed-3906161
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39061612014-01-31 Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation Schirer, Yulie Malishkevich, Anna Ophir, Yotam Lewis, Jada Giladi, Eliezer Gozes, Illana PLoS One Research Article Tauopathy, a major pathology in Alzheimer's disease, is also found in ∼50% of frontotemporal dementias (FTDs). Tau transcript, a product of a single gene, undergoes alternative splicing to yield 6 protein species, each with either 3 or 4 microtubule binding repeat domains (tau 3R or 4R, associated with dynamic and stable microtubules, respectively). While the healthy human brain shows a 1/1 ratio of tau 3R/4R, this ratio may be dramatically changed in the FTD brain. We have previously discovered that activity-dependent neuroprotective protein (ADNP) is essential for brain formation in the mouse, with ADNP+/− mice exhibiting tauopathy, age-driven neurodegeneration and behavioral deficits. Here, in transgenic mice overexpressing a mutated tau 4R species, in the cerebral cortex but not in the cerebellum, we showed significantly increased ADNP expression (∼3-fold transcripts) in the cerebral cortex of young transgenic mice (∼disease onset), but not in the cerebellum, as compared to control littermates. The transgene-age-related increased ADNP expression paralleled augmented dynamic tau 3R transcript level compared to control littermates. Blocking mutated tau 4R transgene expression resulted in normalization of ADNP and tau 3R expression. ADNP was previously shown to be a member of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex. Here, Brahma (Brm), a component of the SWI/SNF complex regulating alternative splicing, showed a similar developmental expression pattern to ADNP. Immunoprecipitations further suggested Brm-ADNP interaction coupled to ADNP - polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF)-binding, with PSF being a direct regulator of tau transcript splicing. It should be noted that although we have shown a correlation between levels of ADNP and tau isoform expression three months of age, we are not presenting evidence of a direct link between the two. Future research into ADNP/tau relations is warranted. Public Library of Science 2014-01-29 /pmc/articles/PMC3906161/ /pubmed/24489906 http://dx.doi.org/10.1371/journal.pone.0087383 Text en © 2014 Schirer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Schirer, Yulie
Malishkevich, Anna
Ophir, Yotam
Lewis, Jada
Giladi, Eliezer
Gozes, Illana
Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title_full Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title_fullStr Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title_full_unstemmed Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title_short Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
title_sort novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (adnp) in the face of tau mutation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906161/
https://www.ncbi.nlm.nih.gov/pubmed/24489906
http://dx.doi.org/10.1371/journal.pone.0087383
work_keys_str_mv AT schireryulie novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation
AT malishkevichanna novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation
AT ophiryotam novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation
AT lewisjada novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation
AT giladieliezer novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation
AT gozesillana novelmarkerfortheonsetoffrontotemporaldementiaearlyincreaseinactivitydependentneuroprotectiveproteinadnpinthefaceoftaumutation